相关实验视频
Updated: May 21, 2025

07:42
Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
18.1K
艾米奥达龙治疗引起的不常见神经肌肉病毒性:病例报告
L El Bahri1, A Bensied2, M Nessnassi2
1Mohammed V University, Rabat, Morocco. elbahri.loubna@gmail.com.
概括
阿米奥达龙可以引起罕见的神经肌肉病,导致腿部软弱和疼痛. 停止服用药物往往会扭转这些症状,改善患者的运动和功能.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
背景情况:
- 阿米奥达龙是一种抗心律失常药物,与罕见但显著的副作用有关.
- 神经肌病,以肌肉软弱和疼痛为特征,是阿米奥达龙治疗的潜在并发症.
- 阿米奥达龙诱导的神经肌肉病的确切机制尚未完全阐明,可能涉及直接的神经毒性或肌肉毒性.
研究的目的:
- 报告一个阿米奥达龙诱导的神经肌肉病的病例.
- 突出这一罕见副作用的诊断挑战和临床表现.
- 强调早期识别和管理的重要性.
主要方法:
- 一个68岁的男性患者的病例介绍,他患有心律失常的右心室发育不良症,长期服用阿米奥达龙.
- 临床评估包括运动强度评估和感官检查.
- 诊断工作包括肌酸激酶,C反应蛋白,脊柱MRI和电肌图 (EMG).
主要成果:
- 患者出现双侧腿部疼痛和虚弱 (运动力2/5) 和触觉感受下降.
- 电肌图显示了一种非长度依赖的感觉运动脱髓化多神经病变.
- 停用阿米奥达龙导致患者的移动性和整体功能显著改善.
结论:
- 神经学检查对于识别罕见的阿米奥达龙诱导并发症,如神经肌病症至关重要.
- 阿米奥达龙诱导的神经肌肉病症在药物停止后往往是可逆的.
- 早期诊断和停止使用阿米奥达龙可以预防长期功能障碍.
相关概念视频
Heart Failure Drugs: Inotropic Agents
479
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
479
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Anticholinesterase Agents: Poisoning and Treatment
763
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
763
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
872
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
872
Local Anesthetics: Adverse Effects
383
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
383
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
380
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
380

